Brogden, Nicole K <br/><br/>
Diclofenac enables unprecedented week-long microneedle-enhanced delivery of a skin impermeable medication in humans.  [electronic resource] 

 -  Pharmaceutical research  Aug 2013 
 - 1947-55 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-904X 
<br/><br/><label>Standard No.: </label>10.1007/s11095-013-1036-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Cutaneous<br/>Adult<br/>Anti-Inflammatory Agents, Non-Steroidal--metabolism<br/>Diclofenac--metabolism<br/>Drug Delivery Systems--methods<br/>Female<br/>Humans<br/>Male<br/>Microinjections--methods<br/>Naltrexone--administration & dosage<br/>Narcotic Antagonists--administration & dosage<br/>Needles<br/>Skin Absorption--drug effects<br/>Young Adult